UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Amarin Corporation plc Following Lighter 2Q13 Sales


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


In a report published Monday, Citigroup analyst Jonathan Eckard reiterated a Buy rating on

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Amarin Corporation plc (NASDAQ: AMRN), and raised the price target from $11.00 to $13.00.In the report, Citigroup noted, “We are lowering our target price to $11 (-$2) and decreasing Vascepa estimates following lighter 2Q:13 sales than expected. While AMRN is laying the tracks to position the drug for favorable reimbursement, we have lowered our near and long-term Vascepa estimates in the current MARINE setting until we see commercial sales pick up. We believe the heightened concerns around the FDA AdComm panel for the ANCHOR filing (Oct. 16) could make the event meaningful upside catalyst if the outcome is ultimately clean.”Amarin Corporation plc closed on Friday at $5.39.
Posted In: Analyst ColorPrice TargetAnalyst RatingsCitigroupJonathan Eckard